文献速递免疫规划卫生政策与健康促进

2017年全球常规疫苗接种覆盖率

Global Routine Vaccination Coverage - 2017.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2018-11-16

MCV1和Pol3覆盖率同样稳定,而MCV2、轮状病毒、PCV、风疹、Hib和乙肝疫苗覆盖率自2007年至2017年有所上升。

要点

  • 全球DTP3覆盖率2010-2017年稳定在84%-85%,未实现GVAP的90%目标。
  • 2007-2017年MCV2、轮状病毒、PCV等疫苗覆盖率显著提升。

核心结论

  • 全球DTP3、MCV1和Pol3覆盖率自2010年以来保持稳定,但未达到GVAP要求的90%国家覆盖率目标。
  • 未接种DTP3的儿童高度集中在10个国家,需采取针对性策略。

研究设计与样本

  • 基于WHO和UNICEF的全球、区域和国家疫苗接种覆盖率估算,更新至2017年。
  • 分析未接种DTP3的存活婴儿数量及国家分布。

主要发现

  • 全球DTP3覆盖率从2007年79%升至2010年84%,2010-2017年稳定在84%-85%。
  • 2007-2017年,10国中5国未接种DTP3儿童数减少,另5国稳定或增加。
  • MCV1覆盖率从2007年80%升至2010年84%,2010-2017年稳定在84%-85%。
  • Pol3覆盖率自2010年以来稳定在84%-85%。

关键数值与推荐

  • GVAP呼吁所有国家到2020年实现国家免疫规划所有疫苗覆盖率≥90%。
  • 全球MCV2覆盖率从2007年33%升至2017年67%。
  • 轮状病毒疫苗全程覆盖率从2%升至28%,PCV从4%升至44%。
  • 风疹疫苗覆盖率从26%升至52%,Hib疫苗从25%升至72%。
  • 乙肝疫苗出生剂量覆盖率从24%升至43%,三剂系列从63%升至84%。

临床怎么用

  • 需针对未接种儿童数量最多的国家制定情境特异性策略以提高并维持高覆盖率。
  • 监测DTP3等关键指标可评估免疫规划绩效并指导资源分配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (GVAP) (1) calls on all countries to reach ≥90% national coverage with all vaccines in the country's national immunization schedule by 2020. This report updates previous reports (2,3) and presents global, regional, and national vaccination coverage estimates and trends as of 2017. It also describes the number of infants surviving to age 1 year (surviving infants) who did not receive the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine (DTP3), a key indicator of immunization program performance (4,5), with a focus on the countries with the highest number of children who did not receive DTP3 in 2017. Based on the World Health Organization (WHO) and United Nations Children's Fund (UNICEF) estimates, global DTP3 coverage increased from 79% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). In 2017, among the 19.9 million children who did not receive DTP3 in the first year of life, 62% (12.4 million) lived in 10 countries. From 2007 to 2017, the number of children who had not received DTP3 decreased in five of these 10 countries and remained stable or increased in the other five. Similar to DTP3 coverage, global coverage with the first measles-containing vaccine dose (MCV1) increased from 80% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). Coverage with the third dose of polio vaccine (Pol3) has remained stable at 84%-85% since 2010. From 2007 to 2017, estimated global coverage with the second MCV dose (MCV2) increased from 33% to 67%, as did coverage with the completed series of rotavirus (2% to 28%), pneumococcal conjugate (PCV) (4% to 44%), rubella (26% to 52%), Haemophilus influenzae type b (Hib) (25% to 72%) and hepatitis B (HepB) (birth dose: 24% to 43%; 3-dose series: 63% to 84%) vaccines. Targeted, context-specific strategies are needed to reach and sustain high vaccination coverage, particularly in countries with the highest number of unvaccinated children.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. VanderEnde K, Gacic-Dobo M, Diallo MS, et al. Global Routine Vaccination Coverage - 2017. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30439873. doi:10.15585/mmwr.mm6745a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。